Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Moderna
Moderna
Page 5 of 18
Health
Pfizer and Moderna boosters keep you safe from Omicron hospitalization, CDC says
By
Fiona Rutherford
and
Bloomberg
January 21, 2022
Health
Moderna chair says COVID could become flu-like endemic in 2022
By
James Paton
and
Bloomberg
January 14, 2022
Health
Pushback grows against fourth COVID vaccine doses, with experts urging caution over expanding booster campaigns
By
David Meyer
January 11, 2022
Health
Doctor says we need to take Omicron more seriously after detailing his son’s symptoms
By
Andrew Marquardt
January 10, 2022
Health
Singapore ranks COVID vaccines by death rate—and Moderna comes out on top
By
Low De Wei
and
Bloomberg
January 10, 2022
Health
With Omicron dominant, new COVID cases are up 254%—and those are just the reported ones
By
Erika Fry
and
Nicolas Rapp
January 5, 2022
Finance
Omicron is upping booster jab demand. So why are COVID vaccine makers’ shares tanking?
By
Jeremy Kahn
December 29, 2021
Health
Moderna hit by shareholders who want to know why its COVID-19 vaccine is so expensive and unavailable in poorer countries
By
David Meyer
December 27, 2021
Health
EU bulks up its arsenal against Omicron with approval of Novavax vaccine. Investors dump shares
By
Christiaan Hetzner
December 20, 2021
Health
Moderna says its COVID-19 booster vaccine delivers a massive increase in antibodies
By
Suzi Ring
,
Naomi Kresge
and
Bloomberg
December 20, 2021
Health
J&J, Sputnik, and Sinopharm vaccines found to be largely ineffective in fighting Omicron: study
By
Bloomberg
December 17, 2021
Health
CDC panel recommends Pfizer and Moderna vaccines over Johnson & Johnson
By
Lauran Neergaard
,
Mike Stobbe
and
The Associated Press
December 16, 2021
International
A desperate Germany turns to vaccine-hesitant Eastern Europe for COVID jabs
By
Christiaan Hetzner
December 16, 2021
Health
As COVID deaths top 800,000, Omicron and Delta variants threaten another U.S. surge
By
Erika Fry
and
Nicolas Rapp
December 15, 2021
Health
Germany’s new health minister delivers a bombshell: The country doesn’t have enough COVID-19 vaccines
By
Christiaan Hetzner
December 15, 2021
Most Popular
Economy
The $38 trillion national debt is to blame for over $1 trillion in annual interest payments from here on out, CRFB says
By
Nick Lichtenberg
AI
'Robots are going to be amongst us': Qualcomm exec says buckle up for the next 5 years. Your car is going to be the...
By
Nino Paoli
C-Suite
Red Lobster CEO Damola Adamolekun says the key to being a better leader is being a better person: ‘Leadership is...
By
Sydney Lake